Epigenetics of induced pluripotency, the seven-headed dragon

Stem Cell Research and Therapy

Volumn 1, Issue 1, 2010, Pages

  Djuric, Ugljesa ^a,b   Ellis, James ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; DNA METHYLATION; EMBRYONIC STEM CELL; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HETEROCHROMATIN; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL;

CELL DIFFERENTIATION; CELL LINEAGE; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC DISEASES, INBORN; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR REPROGRAMMING; TRANSCRIPTION FACTORS;

IPS;

EID: 79951859664     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt3     Document Type: Review

References (53)

1. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
2. Dissecting direct reprogramming through integrative genomic analysis. Mikkelsen T Hanna J, Zhang X Ku M, Wernig M Schorderet P, Bernstein B Jaenisch R, Lander E Meissner A, Nature 2008 454 49 55 10.1038/nature07056 18509334 (Pubitemid 351931978)
3. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Wernig M Meissner A, Foreman R Brambrink T, Ku M Hochedlinger K, Bernstein B Jaenisch R, Nature 2007 448 318 324 10.1038/nature05944 17554336 (Pubitemid 47080337)
4. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Maherali N Sridharan R, Xie W Utikal J, Eminli S Arnold K, Stadtfeld M Yachechko R, Tchieu J Jaenisch R, Plath K Hochedlinger K, Cell Stem Cell 2007 1 55 70 10.1016/j.stem.2007.05.014 18371336
5. Generation of germline-competent induced pluripotent stem cells. Okita K Ichisaka T Yamanaka S,, Nature 2007 448 313 317 10.1038/nature05934 17554338 (Pubitemid 47080336)
6. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Chan EM Ratanasirintrawoot S, Park IH Manos PD, Loh YH Huo H, Miller JD Hartung O, Rho J Ince TA, Daley GQ Schlaeger TM, Nat Biotechnol 2009 27 1033 1037 10.1038/nbt.1580 19826408
7. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Masaki H Ishikawa T Takahashi S Okumura M, Sakai N Haga M, Kominami K Migita H, McDonald F Shimada F, Sakurada K,, Stem Cell Res 2007 1 105 115 10.1016/j.scr.2008.01.001 19383391 (Pubitemid 351726532)
8. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Papapetrou E Tomishima M, Chambers S Mica Y, Reed E Menon J, Tabar V Mo Q, Studer L Sadelain M, Proc Natl Acad Sci USA 2009 106 12759 12764 10.1073/pnas.0904825106 19549847
9. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K Tanabe K Ohnuki M Narita M, Ichisaka T Tomoda K, Yamanaka S,, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
10. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Hotta A Cheung AY, Farra N Vijayaragavan K, Séguin CA Draper JS, Pasceri P Maksakova IA, Mager DL Rossant J, Bhatia M Ellis J, Nat Methods 2009 6 370 376 10.1038/nmeth.1325 19404254
11. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Aoi T Yae K, Nakagawa M Ichisaka T, Okita K Takahashi K, Chiba T Yamanaka S, Science 2008 321 699 702 10.1126/science.1154884 18276851
12. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Hanna J Markoulaki S Schorderet P Carey BW, Beard C Wernig M, Creyghton MP Steine EJ, Cassady JP Foreman R, Lengner CJ Dausman JA, Jaenisch R,, Cell 2008 133 250 264 10.1016/j.cell.2008.03.028 18423197 (Pubitemid 351508307)
13. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Stadtfeld M Brennand K Hochedlinger K,, Curr Biol 2008 18 890 894 10.1016/j.cub.2008.05.010 18501604
14. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Wernig M Lengner C Hanna J Lodato M, Steine E Foreman R, Staerk J Markoulaki S, Jaenisch R,, Nat Biotechnol 2008 26 916 924 10.1038/nbt1483 18594521
15. Oct4-induced pluripotency in adult neural stem cells. Kim JB Sebastiano V, Wu G Arazo-Bravo MJ, Sasse P Gentile L, Ko K Ruau D, Ehrich M Boom, van den D Meyer J Hübner K, Bernemann C Ortmeier C, Zenke M Fleischmann BK, Zaehres H Schöler HR, Cell 2009 136 411 419 10.1016/j.cell.2009.01.023 19203577
16. Elite and stochastic models for induced pluripotent stem cell generation. Yamanaka S, Nature 2009 460 49 52 10.1038/nature08180 19571877
17. Direct cell reprogramming is a stochastic process amenable to acceleration. Hanna J Saha K, Pando B van Zon J, Lengner CJ Creyghton MP, van Oudenaarden A Jaenisch R, Nature 2009 462 595 601 10.1038/nature08592 19898493
18. Epigenetic signatures of stem-cell identity. Spivakov M Fisher AG, Nat Rev Genet 2007 8 263 271 10.1038/nrg2046 17363975
19. Human DNA methylomes at base resolution show widespread epigenomic differences. Lister R Pelizzola M, Dowen RH Hawkins RD, Hon G Tonti-Filippini J, Nery JR Lee L, Ye Z Ngo QM, Edsall L Antosiewicz-Bourget J, Stewart R Ruotti V, Millar AH Thomson JA, Ren B Ecker JR, Nature 2009 462 315 322 10.1038/nature08514 19829295
20. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Meissner A Wernig M Jaenisch R,, Nat Biotechnol 2007 25 1177 1181 10.1038/nbt1335 17724450 (Pubitemid 47538112)
21. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Stadtfeld M Maherali N, Breault D Hochedlinger K, Cell Stem Cell 2008 2 230 240 10.1016/j.stem.2008.02.001 18371448
22. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nakagawa M Koyanagi M, Tanabe K Takahashi K, Ichisaka T Aoi T, Okita K Mochiduki Y, Takizawa N Yamanaka S, Nat Biotechnol 2008 26 101 106 10.1038/nbt1374 18059259
23. Two supporting factors greatly improve the efficiency of human iPSC generation. Zhao Y Yin X Qin H Zhu F, Liu H Yang W, Zhang Q Xiang C, Hou P Song Z, Liu Y Yong J, Zhang P Cai J, Liu M Li H, Li Y Qu X, Cui K Zhang W, Xiang T Wu Y, Zhao Y Liu C, Yu C Yuan K, Lou J Ding M, Deng H,, Cell Stem Cell 2008 3 475 479 10.1016/j.stem.2008.10.002 18983962
24. Role of the murine reprogramming factors in the induction of pluripotency. Sridharan R Tchieu J, Mason M Yachechko R, Kuoy E Horvath S, Zhou Q Plath K, Cell 2009 136 364 377 10.1016/j.cell.2009.01.001 19167336
25. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Liang J Wan M Zhang Y Gu P, Xin H Jung S, Qin J Wong J, Cooney A Liu D, Songyang Z,, Nat Cell Biol 2008 10 731 739 10.1038/ncb1736 18454139 (Pubitemid 351772939)
26. Mbd3, a component of NuRD/Mi-2 complex, helps maintain pluripotency of mouse embryonic stem cells by repressing trophectoderm differentiation. Zhu D Fang J, Li Y Zhang J, PLoS ONE 2009 4 7684 10.1371/journal.pone.0007684 19888462
27. Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Yuan P Han J, Guo G Orlov YL, Huss M Loh YH, Yaw LP Robson P, Lim B Ng HH, Genes Dev 2009 23 2507 2520 10.1101/gad.1831909 19884257
28. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Shi Y Desponts C, Do JT Hahm HS, Scholer HR Ding S, Cell Stem Cell 2008 3 568 574 10.1016/j.stem.2008.10.004 18983970
29. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Huangfu D Maehr R Guo W Eijkelenboom A, Snitow M Chen AE, Melton DA,, Nat Biotechnol 2008 26 795 797 10.1038/nbt1418 18568017 (Pubitemid 351961456)
30. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Feng B Ng J, Heng J Ng H, Cell Stem Cell 2009 4 301 312 10.1016/j.stem.2009.03.005 19341620
31. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Li W Ding S, Trends Pharmacol Sci 2009 31 36 45 10.1016/j.tips.2009.10.002 19896224
32. Promotion of reprogramming to ground state pluripotency by signal inhibition. Silva J Barrandon O, Nichols J Kawaguchi J, Theunissen T Smith A, PLoS Biol 2008 6 253 10.1371/journal.pbio.0060253 18942890
33. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Gaspar-Maia A Alajem A Polesso F Sridharan R, Mason MJ Heidersbach A, Ramalho-Santos J McManus MT, Plath K Meshorer E, Ramalho-Santos M,, Nature 2009 460 863 868 19587682
34. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Jackson-Grusby L Beard C Possemato R Tudor M, Fambrough D Csankovszki G, Dausman J Lee P, Wilson C Lander E, Jaenisch R,, Nat Genet 2001 27 31 39 10.1038/83730 11137995 (Pubitemid 32044515)
35. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Palii SS Van Emburgh BO Sankpal UT Brown KD, Robertson KD,, Mol Cell Biol 2008 28 752 771 10.1128/MCB.01799-07 17991895
36. Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. Karantzal E Schulz H, Hummel O Hubner N, Hatzopoulos A Kretsovali A, Genome Biol 2008 9 65 10.1186/gb-2008-9-4-r65 18394158
37. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Meshorer E Yellajoshula D, George E Scambler P, Brown D Misteli T, Dev Cell 2006 10 105 116 10.1016/j.devcel.2005.10.017 16399082 (Pubitemid 43025681)
38. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Yang L Soonpaa MH, Adler ED Roepke TK, Kattman SJ Kennedy M, Henckaerts E Bonham K, Abbott GW Linden RM, Field LJ Keller GM, Nature 2008 453 524 528 10.1038/nature06894 18432194
39. Directed differentiation of embryonic stem cells into motor neurons. Wichterle H Lieberam I, Porter JA Jessell TM, Cell 2002 110 385 397 10.1016/S0092-8674(02)00835-8 12176325
40. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Murry CE Keller G, Cell 2008 132 661 680 10.1016/j.cell.2008.02.008 18295582 (Pubitemid 351260059)
41. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Dimos JT Rodolfa KT Niakan KK Weisenthal LM, Mitsumoto H Chung W, Croft GF Saphier G, Leibel R Goland R, Wichterle H Henderson CE, Eggan K,, Science 2008 321 1218 1221 10.1126/science.1158799 18669821
42. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Lee G Papapetrou EP Kim H Chambers SM, Tomishima MJ Fasano CA, Ganat YM Menon J, Shimizu F Viale A, Tabar V Sadelain M, Studer L,, Nature 2009 461 402 406 10.1038/nature08320 19693009
43. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Raya A Rodríguez-Piz I Guenechea G Vassena R, Navarro S Barrero MJ, Consiglio A Castell M, Río P Sleep E, Gonzlez F Tiscornia G, Garreta E Aasen T, Veiga A Verma IM, Surrallés J Bueren J, Izpisa Belmonte JC,, Nature 2009 460 53 59 10.1038/nature08129 19483674
44. Induced pluripotent stem cells from a spinal muscular atrophy patient. Ebert AD Yu J Rose FF Jr Mattis VB, Lorson CL Thomson JA, Svendsen CN,, Nature 2009 457 277 280 10.1038/nature07677 19098894
45. Disease-specific induced pluripotent stem cells. Park IH Arora N, Huo H Maherali N, Ahfeldt T Shimamura A, Lensch MW Cowan C, Hochedlinger K Daley GQ, Cell 2008 134 877 886 10.1016/j.cell.2008.07.041 18691744
46. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. Hotta A Ellis J, J Cell Biochem 2008 105 940 948 10.1002/jcb.21912 18773452
47. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Chin MH Mason MJ Xie W Volinia S, Singer M Peterson C, Ambartsumyan G Aimiuwu O, Richter L Zhang J, Khvorostov I Ott V, Grunstein M Lavon N, Benvenisty N Croce CM, Clark AT Baxter T, Pyle AD Teitell MA, Pelegrini M Plath K, Lowry WE,, Cell Stem Cell 2009 5 111 123 10.1016/j.stem.2009.06.008 19570518
48. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Doi A Park IH, Wen B Murakami P, Aryee MJ Irizarry R, Herb B Ladd-Acosta C, Rho J Loewer S, Miller J Schlaeger T, Daley GQ Feinberg AP, Nat Genet 2009 41 1350 1353 10.1038/ng.471 19881528
49. Marked differences in differentiation propensity among human embryonic stem cell lines. Osafune K Caron L Borowiak M Martinez RJ, Fitz-Gerald CS Sato Y, Cowan CA Chien KR, Melton DA,, Nat Biotechnol 2008 26 313 315 10.1038/nbt1383 18278034 (Pubitemid 351355125)
50. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Chang HH Hemberg M Barahona M Ingber DE, Huang S,, Nature 2008 453 544 547 10.1038/nature06965 18497826 (Pubitemid 351733323)
51. Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. Kalmar T Lim C Hayward P Mũoz-Descalzo S, Nichols J Garcia-Ojalvo J, Martinez Arias A,, PLoS Biol 2009 7 1000149 10.1371/journal.pbio.1000149 19582141
52. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Hayashi K Lopes S, Tang F Surani M, Cell Stem Cell 2008 3 391 401 10.1016/j.stem.2008.07.027 18940731
53. Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Belmonte JC Ellis J, Hochedlinger K Yamanaka S, Nat Rev Genet 2009 10 878 883 19859062